Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

Scientists have found that the anti-seizure medication levetiracetam prevents the buildup of faulty amyloid-beta proteins in ...

SGLT2 inhibitors are already used to treat diabetes and chronic kidney disease. This study helps explain why patients taking ...

Donanemab slowed cognitive decline by about 35% in a phase 3 clinical trial, according to a report released Monday. Another drug is showing promise for those at risk of Alzheimer's disease. Donanemab, ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are ...

A new Cell Metabolism study finds semaglutide drugs like Ozempic may slow osteoarthritis and protect cartilage through direct ...

Drug maker Novo Nordisk says semaglutide, the active ingredient for the weight loss jab Wegovy, does not slow Alzheimer's - despite initial hopes that it might help against dementia. Researchers began ...